Erika Biegelmeyer
Sao Paulo, SP 04023062, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of SARS-CoV-2 Vaccination on Disease Activity and Severity of COVID-19 Infection in Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study.
Journal: Vaccines
Published: September 07, 2025
Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis.
Journal: Frontiers in immunology
Published: June 28, 2025
Brazilian Society of Rheumatology - 2025 recommendations on vaccination in immune-mediated rheumatic diseases.
Journal: Advances in rheumatology (London, England)
Published: June 17, 2025
Comparison of the immunogenicity and safety among COVID-19 vaccines ChadOx-1, CoronaVac and BNT162b2 in systemic lupus erythematosus (SLE) patients: a prospective cohort.
Journal: Advances in rheumatology (London, England)
Published: December 26, 2024
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.
Journal: Vaccines
Published: November 15, 2024
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.
Journal: Vaccines
Published: October 29, 2024
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.
Journal: Vaccines
Published: July 31, 2024
Rare primary vasculitis: update on multiple complex diseases and the new kids on the block.
Journal: Advances in rheumatology (London, England)
Published: March 04, 2024
Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer.
Journal: Advances in rheumatology (London, England)
Published: October 03, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026